CLINICAL AND COST OUTCOMES OF TREATMENT WITH INSULIN GLARGINE VERSUS INSULIN DETEMIR IN INSULIN NAïVE TYPE 2 DIABETES PATIENTS- COST-EFFECTIVENESS ANALYSIS IN THE KAZAKHSTAN SETTING
Abstract
Authors
A. Kostyuk A. Akanov A. Almadiyeva